Nicholas Metrus, MD

Dr. Nicholas Metrus is a board-certified, fellowship-trained neurologist/neuro-oncologist with Atlantic Medical Group Neuroscience Associates and the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He is a specialist in the diagnosis and treatment of patients with brain tumors and conditions of the central nervous system. Dr. Metrus is part of a medical team that works together to provide exceptional personalized care for every patient using a multidisciplinary and comprehensive approach. His commitment to individualized care includes designing and overseeing each patient’s treatment plan, which can include any combination of chemotherapy, target therapy, and immunotherapy. Throughout his medical education, Dr. Metrus devoted his time to cutting-edge research and publishing his work on topics such as paraneoplastic disorders, tumefactive multiple sclerosis, and clinical trial enrollment, to name a few. He has also published book chapters on ependymomas and advances in clinical trial design for brain tumors. He pursed his fellowship training in neuro-oncology at MD Anderson Cancer Center, where he was the 2018 recipient of a research grant, the William James Miller Endowed Fellowship Award, for his work in Guillain Barre Syndrome following stem cell transplants, and again in 2019 for his description of unique presentations of cancer in the brain. His research on hypermutator gliomas has been presented at national and international medical conferences. Dr. Metrus earned his medical degree from the American University of the Caribbean and went on to complete his residency in neurology at the University of Texas Medical Branch. Dr. Metrus is a participating provider of the Atlantic Accountable Care Organization.